Dr. Duska on Primary Debulking Surgery in Ovarian Cancer

Video

In Partnership With:

Linda R. Duska, MD, discusses primary debulking surgery in ovarian cancer.

Linda R. Duska, MD, professor of obstetrics and gynecology and gynecologic oncologist at the University of Virginia, discusses primary debulking surgery in ovarian cancer.

Primary debulking surgery has demonstrated improved overall survival for patients. However, the procedure can lead to surgical complications. For example, primary debulking surgery has been associated with an increased rate of surgical morbidity or mortality in some patients, says Duska.

As such, patient-related factors including performance status, serum albumin levels, BMI, and other medical comorbidities may lead a surgeon to discuss neoadjuvant chemotherapy with the patient as a less morbid alternative to surgery, concludes Duska.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS